Epidemiology and Outcomes of Candidemia in a Referral Center in Tehran
Open Access
- 1 January 2019
- journal article
- research article
- Vol. 10 (1), 73-79
- https://doi.org/10.22088/CJIM.10.1.73
Abstract
Background: Bloodstream infection with Candida, or candidemia, is the most common Candida systemic infection. In this study, we investigated the characteristics of patients with candidemia to provide appropriate perspectives on these patients and reduce the associated mortality and morbidity. Methods: In this cross-sectional study, all patients with at least one positive blood culture of Candida spp. were investigated from April 2015 to March 2016 in Imam Khomeini Hospital Complex, Tehran, Iran. Results: A total of 74 patients (44 men and 30 women), with the mean age of 53.15 +/- 17.89 years, were enrolled in this study. Non-albicans Candida species was responsible for candidemia in 67.6% (50.74). The mean therapy intervals were 7 and 5.6 +/- 1.5 days in patients who died and were discharged, respectively. The differences in frequencies of urinary catheter and mechanical ventilation were statistically significant among patients who died and survived (P<0.001). Among the discharged patients, antifungal therapy was administered to 30.8% (12.39). The mortality rate was 54.3% (19.35) in the medical ward, 5.7% (2.35) in the surgical ward, and 40% (14.35) in the intensive care unit (P=0.041). The treatment was significantly associated with lower mortality than those with no treatment (OR=0.150 [0.023-0.996], P=0.05). Conclusion: The number of candidemia cases caused by non-albicans Candida species is continuously increasing in our center. We demonstrated the epidemiologic characteristics of patients with candidemia and the significant effects of timely and appropriate treatment on their outcomes. Further studies are needed to illuminate more aspects of this healthcare problem.Keywords
This publication has 35 references indexed in Scilit:
- Candida albicanspathogenicity mechanismsVirulence, 2013
- Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream InfectionAntimicrobial Agents and Chemotherapy, 2012
- Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in ItalyPLOS ONE, 2011
- Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infectionsAmerican Journal of Infection Control, 2010
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Determinants of mortality in non-neutropenic ICU patients with candidaemiaCritical Care, 2009
- Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center ExperienceThe Korean Journal of Internal Medicine, 2009
- C. albicans Colonization of Human Mucosal SurfacesPLOS ONE, 2008
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005